His research focuses on developing new methods for the formation of carbon-carbon bonds. This plays an important role in the synthesis of a widerange of chemical structures, including drugs that are used to treat a variety of diseases. He is a co-inventor on Faldaprivir, an orally bioavailable drug for the treatment of hepatitis C virus and is currently developing a new anti-cancer drug with a novel mechanism of action.